Larvol Delta - Anixa-Biosciences-and-Cleveland-Clinic-Present-New-Updated-Positive-Data-from-Phase-1-Study-of-Breast-Cancer-Vaccine-at-the-39th-Society-for-Immunotherapy-of-Cancer-SITC-Annual-Meeting

alpha-lactalbumin vaccine - Anixa Biosci, Cleveland Clinic

https://www.prnewswire.com/news-releases/anixa-biosciences-and-cleveland-clinic-present-new-updated-positive-data-from-phase-1-study-of-breast-cancer-vaccine-at-the-39th-society-for-immunotherapy-of-cancer-sitc-annual-meeting-302299962.html

Nov 8, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next